GORE® CARDIOFORM Septal Occluder

DEVICE2 trials

Sponsors

W.L.Gore & Associates

Conditions

Cryptogenic StrokePFO - Patent Foramen OvaleSeptal Defect, AtrialStrokeTIA

Unknown Phase

Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects

CompletedNCT01711983

W.L.Gore & AssociatesSeptal Defect, Atrial

Start: 2012-10-31End: 2018-11-26Updated: 2020-08-21

Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder

Active, not recruitingNCT05529901

W.L.Gore & AssociatesCryptogenic Stroke, PFO - Patent Foramen Ovale, Stroke +1

Start: 2022-10-03End: 2029-08-31Target: 300Updated: 2025-11-20